Abbott Laboratories Gets Global Rights To Advanced Life’s ProGRP

May 16, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CHICAGO, May 16 (Reuters) - Abbott Laboratories Inc. on Tuesday said it entered into a licensing agreement with Advanced Life Science Institute Inc. to develop a test for small-cell lung cancer, an aggressive form of the disease.

Twitter
LinkedIn
Facebook
Email
Print

Alliances

Abbott Laboratories